UNILAG Alumnus, Prof. Azeez Butali, Recognized for Outstanding Contributions to Research and Alumni Engagement

The University of Lagos (UNILAG) proudly celebrates Professor Azeez Butali, a distinguished alumnus whose remarkable contributions to research and his alma mater continue to make a lasting impact.

Prof. Butali, a globally recognized expert in genetics research, has dedicated his work to the study of cleft conditions in Nigerians, collaborating extensively with faculty members at the College of Medicine, University of Lagos (CMUL). His commitment to advancing medical research has led to the facilitation of over seven NIH-funded grants to CMUL in the past decade, significantly enhancing research capacity and innovation within the institution.

Appointments and Research Focus
Prof. Butali currently serves as an Assistant Professor in the Department of Oral Pathology, Radiology, and Medicine at the College of Dentistry. While many focus on treating cleft palates, he is pioneering innovative approaches to prevent them. His genetic study of non-syndromic clefts in people of African descent is funded through a prestigious grant from the National Institute for Dental and Craniofacial Research.

Beyond his groundbreaking research, Prof. Butali also leads the African Craniofacial Anomalies Network, a collaboration between scientists in Ghana, Ethiopia, Kenya, Nigeria, and Rwanda, working together to advance research and improve healthcare outcomes for craniofacial anomalies.

Alumni Leadership and Impact
In addition to his research, Prof. Butali is deeply committed to his alma mater. He currently serves as the Chairperson of the UNILAG Dental School Alumni and plays a key role in mentoring young professionals as an Associate Lecturer at the Faculty.

The UNILAG alumni community commends Prof. Azeez Butali for his outstanding achievements, his dedication to research, and his unwavering support for the university. His work continues to inspire the next generation of scholars and healthcare professionals, solidifying his legacy as a leader in both academia and medical innovation.